Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 40.
Article
Abani, O;
Abbas, A;
Abbas, F;
Abbas, M;
Abbasi, S;
Abbass, H;
Abbott, A;
... et alia, .; + view all
(2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
The Lancet
, 397
(10285)
pp. 1637-1645.
10.1016/S0140-6736(21)00676-0.
|
Abouyannis, M;
Aggarwal, D;
Lalloo, DG;
Casewell, NR;
Hamaluba, M;
Esmail, H;
(2021)
Clinical outcomes and outcome measurement tools reported in randomised controlled trials of treatment for snakebite envenoming: A systematic review.
PLOS Neglected Tropical Diseases
, 15
(8)
, Article e000958. 10.1371/journal.pntd.0009589.
|
Achar, Jay;
Seddon, James A;
Knight, Gwenan M;
Dodd, Peter J;
Esmail, Hanif;
Hughes, Jennifer;
McQuaid, C Finn;
(2023)
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.
European Respiratory Journal
, 62
(5)
, Article 2300969. 10.1183/13993003.00969-2023.
|
Chaudhry, Z;
Shawe-Taylor, M;
Rampling, T;
Cutfield, T;
Bidwell, G;
Chan, XHS;
Last, A;
... Esmail, H; + view all
(2021)
Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate.
Journal of Infection
10.1016/j.jinf.2021.03.002.
(In press).
|
Coussens, AK;
Zaidi, SMA;
Allwood, BW;
Dewan, PK;
Gray, G;
Kohli, M;
Kredo, T;
... Yi, S; + view all
(2024)
Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise.
The Lancet Respiratory Medicine
, 12
(6)
pp. 484-498.
10.1016/S2213-2600(24)00028-6.
|
Cunniffe, NG;
Gunter, SJ;
Brown, M;
Burge, SW;
Coyle, C;
De Soyza, A;
Dymond, T;
... Toshner, M; + view all
(2020)
How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis.
BMJ Open
, 10
(10)
, Article e044566. 10.1136/bmjopen-2020-044566.
|
du Bruyn, E;
Stek, C;
Daroowala, R;
Said-Hartley, Q;
Hsiao, M;
Schafer, G;
Goliath, RT;
... Wilkinson, RJ; + view all
(2023)
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa.
Nature Communications
, 14
(1)
, Article 188. 10.1038/s41467-022-35689-1.
|
Esmail, Hanif;
Macpherson, Liana;
Coussens, Anna K;
Houben, Rein MGJ;
(2022)
Mind the gap - Managing tuberculosis across the disease spectrum.
EBioMedicine
, Article 103928. 10.1016/j.ebiom.2022.103928.
|
Esmail, H;
Dodd, PJ;
Houben, RMGJ;
(2018)
Tuberculosis transmission during the subclinical period: could unrelated cough play a part?
Lancet Respiratory Medicine
, 6
(4)
pp. 244-246.
10.1016/S2213-2600(18)30105-X.
|
Esmail, H;
Lai, RP;
Lesosky, M;
Wilkinson, KA;
Graham, CM;
Coussens, AK;
Oni, T;
... Wilkinson, RJ; + view all
(2016)
Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography.
Nature Medicine
, 22
pp. 1090-1093.
10.1038/nm.4161.
|
Esmail, H;
Lai, RP;
Lesosky, M;
Wilkinson, KA;
Graham, CM;
Horswell, S;
Coussens, AK;
... Wilkinson, RJ; + view all
(2018)
Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis.
Proceedings of the National Academy of Sciences of the United States of America
, 115
(5)
E964-E973.
10.1073/pnas.1711853115.
|
Esmail, H;
Lipman, MC;
Nunn, A;
Walker, TM;
(2019)
Individualising therapy for drug-sensitive tuberculosis.
The Lancet Respiratory Medicine
, 7
(10)
pp. 834-835.
10.1016/S2213-2600(19)30247-4.
|
Frascella, B;
Richards, AS;
Sossen, B;
Emery, JC;
Odone, A;
Law, I;
Onozaki, I;
... Houben, RMGJ; + view all
(2020)
Subclinical tuberculosis disease - a review and analysis of prevalence surveys to inform definitions, burden, associations and screening methodology.
Clinical Infectious Diseases
10.1093/cid/ciaa1402.
(In press).
|
Gray, A;
Surey, J;
Veitch, M;
Menezes, D;
Gibbons, J;
Leonard, M;
Sultan, B;
... Story, A; + view all
(2024)
Diagnosis and management of tuberculosis infection in inclusion health populations in London.
BMC Infectious Diseases
, 24
(1)
, Article 252. 10.1186/s12879-024-09132-3.
|
Gray, Adam Thorburn;
Macpherson, Liana;
Carlin, Ffion;
Sossen, Bianca;
Richards, Alexandra S;
Kik, Sandra V;
Houben, Rein MGJ;
... Esmail, Hanif; + view all
(2023)
Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis.
PLoS One
, 18
(11)
, Article e0293535. 10.1371/journal.pone.0293535.
|
Gray, AT;
Surey, J;
Esmail, H;
Story, A;
Harris, M;
(2022)
"It's too hard" - the management of latent TB in under-served populations in the UK: a qualitative study.
BMC health services research
, 22
, Article 1464. 10.1186/s12913-022-08855-w.
|
Gray, AT;
Boyles, T;
Luedtke, S;
Sossen, B;
Birjovanu, G;
Kostkova, P;
Hughes, J;
(2020)
A threat to decentralised care for drug-resistant tuberculosis.
The Lancet Respiratory Medicine
, 8
(10)
pp. 950-952.
10.1016/S2213-2600(20)30392-1.
|
Gray, AT;
Wood, CE;
Boyles, T;
Luedtke, S;
Birjovanu, G;
Hughes, J;
Kostkova, P;
(2021)
Following Guidelines for Drug-Resistant Tuberculosis: “Yes, it’s a challenge”.
Frontiers in Tropical Diseases
, 2
, Article 645933. 10.3389/fitd.2021.645933.
|
Gupta, RK;
Turner, CT;
Venturini, C;
Esmail, H;
Rangaka, MX;
Copas, A;
Lipman, M;
... Noursadeghi, M; + view all
(2020)
Concise whole blood transcriptional signatures for incipient
tuberculosis: a systematic review and patient-level pooled
meta-analysis.
The Lancet Respiratory Medicine
10.1016/S2213-2600(19)30282-6.
(In press).
|
Horton, KC;
Richards, AS;
Emery, JC;
Esmail, H;
Houben, RMGJ;
(2023)
Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis.
Proceedings of the National Academy of Sciences of the United States of America
, 120
(47)
, Article e2221186120. 10.1073/pnas.2221186120.
|
Kahan, BC;
Morris, TP;
White, IR;
Tweed, CD;
Cro, S;
Dahly, D;
Pham, TM;
... Carpenter, JR; + view all
(2020)
Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions.
BMC Medicine
, 18
(1)
, Article 286. 10.1186/s12916-020-01737-0.
|
Kloprogge, F;
Abubakar, I;
Esmail, H;
Hack, V;
Kunst, H;
McHugh, TD;
Noursadeghi, M;
... Lipman, M; + view all
(2021)
Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study.
BMJ Open
, 11
(7)
, Article e052885. 10.1136/bmjopen-2021-052885.
|
MacPherson, P;
Williams, CM;
Burke, RM;
Barer, MR;
Esmail, H;
(2021)
Before the whistle blows: developing new paradigms in tuberculosis screening to maximise benefit and minimise harm [version 1; peer review: awaiting peer review].
Wellcome Open Research
, 6
, Article 8. 10.12688/wellcomeopenres.16506.1.
|
Noor, NM;
Pett, SL;
Esmail, H;
Crook, AM;
Vale, CL;
Sydes, MR;
Parmar, MKB;
(2020)
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings [version 2; peer review: 2 approved].
F1000Research
, 9
, Article 1109. 10.12688/f1000research.26253.2.
|
Parmar, MKB;
Noor, NM;
Pett, SL;
Esmail, H;
Crook, AM;
Vale, CL;
Sydes, MR;
(2020)
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings [version 1; peer review: 2 approved].
F1000Research
, 9
, Article 1109. 10.12688/f1000research.26253.1.
|
Peterson, TE;
Baker, J;
Wong, L-Y;
Rupert, A;
Ntusi, NAB;
Esmail, H;
Wilkinson, R;
... Thienemann, F; + view all
(2020)
Elevated N‐terminal prohormone of brain natriuretic peptide among persons living with HIV in a South African peri‐urban township.
ESC Heart Failure
10.1002/ehf2.12849.
(In press).
|
Porter, JC;
Inshaw, J;
Solis, VJ;
Denneny, E;
Evans, R;
Temkin, MI;
De Vasconcelos, N;
... Papayannopoulos, V; + view all
(2023)
Anti-inflammatory therapy with nebulised dornase alfa in patients with severe COVID-19 pneumonia A Randomised Clinical Trial.
eLife
, 12
10.7554/eLife.87030.1.
(In press).
|
RECOVERY Collaborative Group;
(2021)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
The Lancet
, 397
(10289)
pp. 2049-2059.
10.1016/S0140-6736(21)00897-7.
|
RECOVERY Collaborative Group, .;
(2021)
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet
, 397
(10274)
pp. 605-612.
10.1016/S0140-6736(21)00149-5.
|
Richards, Alexandra S;
Sossen, Bianca;
Emery, Jon C;
Horton, Katherine C;
Heinsohn, Torben;
Frascella, Beatrice;
Balzarini, Federica;
... Houben, Rein MGJ; + view all
(2023)
Quantifying progression and regression across the spectrum of pulmonary tuberculosis: a data synthesis study.
Lancet Global Health
10.1016/S2214-109X(23)00082-7.
(In press).
|
Shaw, Emily S;
Stoker, Neil G;
Potter, Jessica L;
Claassen, Helgard;
Leslie, Alasdair;
Tweed, Conor;
Chiang, Chen-Yuan;
... Lipman, Marc; + view all
(2024)
Bedaquiline: what might the future hold?
Lancet Microbe
, 5
(12)
, Article 100909. 10.1016/S2666-5247(24)00149-6.
|
Sheerin, D;
Lakay, F;
Esmail, H;
Kinnear, C;
Sansom, B;
Glanzmann, B;
Wilkinson, RJ;
... Coussens, AK; + view all
(2023)
Identification and control for the effects of bioinformatic globin depletion on human RNA-seq differential expression analysis.
Scientific Reports
, 13
, Article 1859. 10.1038/s41598-023-28218-7.
|
Sossen, Bianca;
Richards, Alexandra S;
Heinsohn, Torben;
Frascella, Beatrice;
Balzarini, Federica;
Oradini-Alacreu, Aurea;
Odone, Anna;
... Esmail, Hanif; + view all
(2023)
The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis.
The Lancet Respiratory Medicine
, 11
(4)
pp. 367-379.
10.1016/S2213-2600(23)00097-8.
|
South, Annabelle;
Dhesi, Parveen;
Tweed, Conor D;
Tsogt, Bazarragchaa;
Staples, Suzanne;
Tukvadze, Nestani;
Dorj, Gantsetseg;
... Burgess, Rochelle; + view all
(2023)
Patients’ priorities around drug-resistant tuberculosis treatment: A multi-national qualitative study from Mongolia, South Africa and Georgia.
Global Public Health. An International Journal for Research, Policy and Practice
, 18
(1)
, Article 2234450. 10.1080/17441692.2023.2234450.
|
The RECOVERY Collaborative Group;
(2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
New England Journal of Medicine
, 383
(21)
pp. 2030-2040.
10.1056/nejmoa2022926.
|
The RECOVERY Collaborative Group;
(2020)
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report.
New England Journal of Medicine
, 383
(21)
pp. 2030-2040.
10.1056/nejmoa2022926.
|
Walker, TM;
Cruz, ALG;
Peto, TE;
Smith, EG;
Esmail, H;
Crook, DW;
(2017)
Tuberculosis is changing.
[Editorial comment].
Lancet Infectious Diseases
, 17
(4)
pp. 359-361.
10.1016/S1473-3099(17)30123-8.
|
|
White, RG;
Churchyard, GJ;
Horton, KC;
Fiore-Gartland, A;
Behr, MA;
Clark, RA;
Cobelens, F;
... Houben, RMGJ; + view all
(2025)
Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials.
The Lancet Respiratory Medicine
, 13
(10)
pp. 933-942.
10.1016/S2213-2600(25)00164-X.
|
Zabala, Guillermo A;
Lever, Robert;
Chan, Xin Hui;
Bristowe, Henrietta;
Kilbride, Emer;
Richards, David;
Daly, Mark;
... Chiodini, Peter L; + view all
(2024)
Autochthonous Human Babesia divergens Infection, England.
Emerging Infectious Diseases
, 30
(10)
pp. 2165-2168.
10.3201/eid3010.240866.
|
Zaidi, SMA;
Coussens, AK;
Seddon, JA;
Kredo, T;
Warner, D;
Houben, RMGJ;
Esmail, H;
(2023)
Beyond latent and active tuberculosis: a scoping review of conceptual frameworks.
eClinicalMedicine
, 66
, Article 102332. 10.1016/j.eclinm.2023.102332.
|